Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone

Background: A combination of low-dose thalidomide and corticosteroids is a treatment option for anaemic patients with primary myelofibrosis (PMF) who are not eligible for allogeneic hematopoietic stem cell transplantation. Methods: We describe the outcomes of 13 patients with PMF treated with thalid...

Full description

Bibliographic Details
Main Authors: Petra Bělohlávková, Vladimír Maisnar, Jaroslava Voglová, Tomáš Buchler, Pavel Žák
Format: Article
Language:English
Published: Karolinum Press 2016-08-01
Series:Acta Medica
Subjects:
Online Access:http://actamedica.lfhk.cuni.cz/59/2/0050/